Latest Breaking News On - Chimerix inc - Page 1 : vimarsana.com

Head-To-Head Comparison: Lipella Pharmaceuticals (NASDAQ:LIPO) and Chimerix (NASDAQ:CMRX)

Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and Chimerix (NASDAQ:CMRX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Insider and Institutional Ownership 74.3% of Lipella Pharmaceuticals […]

North-carolina
United-states
Pennsylvania
Chimerix-inc
Symbio-pharmaceuticals
Lipella-pharmaceuticals-inc
News-ratings-for-lipella-pharmaceuticals-daily
Lipella-pharmaceuticals
Get-free-report
Given-chimerix
Pharmaceuticals-inc

StockNews.com Lowers Chimerix (NASDAQ:CMRX) to Sell

StockNews.com Lowers Chimerix (NASDAQ:CMRX) to Sell
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Vance-wealth-inc
Chimerix-inc
York-mellon-corp
Free-report
Trading-down
Get-free-report
New-york-mellon-corp
Fire-capital
Chimerix-daily

StockNews.com Downgrades Chimerix (NASDAQ:CMRX) to Sell

Chimerix (NASDAQ:CMRX – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday. A number of other brokerages also recently commented on CMRX. HC Wainwright restated a “buy” rating and issued a $11.00 target price on shares of […]

Marquette-asset-management
Koshinski-asset-management-inc
Chimerix-inc
Vance-wealth-inc
Get-free-report
Trading-down
Asset-management
Pale-fire-capital
Chimerix-daily

Chimerix (NASDAQ:CMRX) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS

Chimerix (NASDAQ:CMRX – Get Free Report) posted its earnings results on Wednesday. The biopharmaceutical company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.04), Zacks reports. Chimerix had a negative return on equity of 39.62% and a negative net margin of 25,337.96%. During the same quarter last […]

Chimerix-inc
Get-free-report
Chimerix-daily
Chimerix
Nasdaq-cmrx
Cmrx
Medical
Earnings

Chimerix (NASDAQ:CMRX) Issues Earnings Results

Chimerix (NASDAQ:CMRX) Issues Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Chimerix-company-profile
Chimerix-inc
Get-free-report
Chimerix-daily

Short Interest in Chimerix, Inc. (NASDAQ:CMRX) Rises By 6.5%

Short Interest in Chimerix, Inc. (NASDAQ:CMRX) Rises By 6.5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Chimerix-inc
Vance-wealth-inc
Chimerix-company-profile
Nasdaq
York-mellon-corp
Get-free-report
Fire-capital
New-york-mellon-corp
Vestal-point-capital
Chimerix-daily

Chimerix, Inc. (NASDAQ:CMRX) Short Interest Update

Chimerix, Inc. (NASDAQ:CMRX) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
York-mellon-corp
Chimerix-inc
Vance-wealth-inc
Chimerix-company-profile
Get-free-report
New-york-mellon-corp
Fire-capital
Chimerix-daily

Chimerix (CMRX) to Release Earnings on Wednesday

Chimerix (CMRX) to Release Earnings on Wednesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Chimerix-inc
Get-free-report
Chimerix-daily

Vance Wealth Inc. Makes New $46,000 Investment in Chimerix, Inc. (NASDAQ:CMRX)

Vance Wealth Inc. purchased a new position in Chimerix, Inc. (NASDAQ:CMRX – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 47,320 shares of the biopharmaceutical company’s stock, valued at approximately $46,000. A number of other large investors have also added to or reduced their stakes in the company. RA Capital Management L.P. […]

York-mellon-corp
Vance-wealth-inc
Nasdaq
Chimerix-inc
Vance-wealth
Free-report
New-york-mellon-corp
Pale-fire-capital
Get-free-report
Visit-holdingschannel
Chimerix-daily

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chimerix-inc
Nasdaq
Willo-connorstern-investor-relations